Aller au contenu principal

Case details

Case Number: ACT_13886/2024

  • Patent number:
    EP3167888 - TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

  • Proceeding type: Proceeding

  • Action/Application: Application for provisional measures

  • Defendants:
    Amgen N.V. Represented by Tilman Müller-Stoy
    Amgen Biofarmacêutica Lda. Represented by Tilman Müller-Stoy
    Amgen GmbH Represented by Tilman Müller-Stoy
    Amgen S.A.S. Represented by Tilman Müller-Stoy
    Amgen Zdravila D.O.O. Represented by Tilman Müller-Stoy
    Amgen GmbH Represented by Tilman Müller-Stoy
    Amgen Technology (Ireland) Unlimited Company Represented by Tilman Müller-Stoy
    Amgen AB Represented by Tilman Müller-Stoy
    Amgen s.r.l. Represented by Tilman Müller-Stoy

  • Applicants:
    Alexion Pharmaceuticals, Inc. Represented by Elena Hennecke

  • Judges:
    Alima Zana
    Rudi Goedeweeck
    Sabine Klepsch
    Stefan Schilling

  • Court Division: First instance, Local division - Hamburg

  • Date of Formal receipt: 2024-03-19 00:00:00

  • Decision date: 2024-06-26 17:51:38

  • Language of proceeding: Anglais